The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III MAGIC trial of APF530 v ondansetron (Ond) with fosaprepitant (Fos) + dexamethasone (Dex) for highly emetogenic chemotherapy (HEC)-induced nausea and vomiting: analysis by age and gender.
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Stock and Other Ownership Interests - Vector Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Genentech; Teva
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Eisai
 
Nashat Y. Gabrail
Honoraria - Boehringer Ingelheim; HERON; Janssen; Onyx; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Boehringer Ingelheim; Janssen; Onyx; Sanofi; Taiho Pharmaceutical
Research Funding - Abbvie; Amgen; Boehringer Ingelheim; Gilead Sciences; HERON; Janssen; Merck; Sanofi
 
John S. Hrom
Honoraria - HERON
Research Funding - Accelovance; Bristol-Myers Squibb; Gilead Sciences; HERON
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Cerulean Pharma; Janssen Biotech; Labceutics; Pfizer
Speakers' Bureau - Bayer; Caris MPI; Dendreon; Genentech/Roche; GlaxoSmithKline; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Michael Mosier
Consulting or Advisory Role - EMB Statistical Solutions
 
Robert B. Geller
Employment - HERON
Stock and Other Ownership Interests - HERON
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - HERON
 
Ian Schnadig
Employment - Compass Oncology
Leadership - Compass Oncology
Honoraria - HERON; Tesaro
Consulting or Advisory Role - HERON; Tesaro
Travel, Accommodations, Expenses - HERON; Tesaro